Insufficient scRNA-seq data for expression of TTI2 at single-cell level.
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 3 studies | 17% ± 2% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 415.87 | 1445 / 1445 | 100% | 8.47 | 183 / 183 |
breast | 100% | 448.56 | 459 / 459 | 99% | 10.53 | 1111 / 1118 |
skin | 100% | 521.35 | 1809 / 1809 | 99% | 9.76 | 468 / 472 |
ovary | 100% | 413.22 | 180 / 180 | 99% | 7.85 | 426 / 430 |
lung | 99% | 383.12 | 575 / 578 | 100% | 7.85 | 1150 / 1155 |
stomach | 100% | 352.94 | 359 / 359 | 99% | 7.68 | 283 / 286 |
intestine | 100% | 436.64 | 966 / 966 | 99% | 7.70 | 521 / 527 |
brain | 99% | 258.08 | 2603 / 2642 | 100% | 8.89 | 704 / 705 |
uterus | 100% | 470.29 | 170 / 170 | 98% | 8.93 | 451 / 459 |
prostate | 100% | 419.55 | 245 / 245 | 98% | 7.26 | 493 / 502 |
thymus | 100% | 445.78 | 653 / 653 | 98% | 7.52 | 593 / 605 |
bladder | 100% | 439.38 | 21 / 21 | 97% | 7.40 | 487 / 504 |
pancreas | 98% | 204.79 | 320 / 328 | 98% | 6.32 | 175 / 178 |
kidney | 100% | 378.43 | 89 / 89 | 95% | 6.03 | 854 / 901 |
adrenal gland | 100% | 527.60 | 258 / 258 | 92% | 6.87 | 212 / 230 |
liver | 100% | 253.50 | 225 / 226 | 78% | 3.47 | 318 / 406 |
adipose | 100% | 430.39 | 1204 / 1204 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 6.70 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 10.88 | 29 / 29 |
spleen | 100% | 575.85 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 10.39 | 45 / 45 |
blood vessel | 100% | 417.30 | 1334 / 1335 | 0% | 0 | 0 / 0 |
muscle | 100% | 424.81 | 802 / 803 | 0% | 0 | 0 / 0 |
heart | 97% | 346.48 | 839 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 97% | 489.84 | 902 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_2000003 | Biological process | positive regulation of DNA damage checkpoint |
GO_0050821 | Biological process | protein stabilization |
GO_0110078 | Cellular component | TTT Hsp90 cochaperone complex |
GO_0005634 | Cellular component | nucleus |
Gene name | TTI2 |
Protein name | TELO2 interacting protein 2 TELO2-interacting protein 2 |
Synonyms | C8orf41 |
Description | FUNCTION: Regulator of the DNA damage response (DDR). Part of the TTT complex that is required to stabilize protein levels of the phosphatidylinositol 3-kinase-related protein kinase (PIKK) family proteins. The TTT complex is involved in the cellular resistance to DNA damage stresses, like ionizing radiation (IR), ultraviolet (UV) and mitomycin C (MMC). Together with the TTT complex and HSP90 may participate in the proper folding of newly synthesized PIKKs. . |
Accessions | Q6NXR4 ENST00000523305.1 ENST00000520636.5 ENST00000360742.9 ENST00000613904.1 E5RIH5 E5RHM7 ENST00000431156.7 |